Machine Learning Characterization of COPD Subtypes

Insights From the COPDGene Study
Published:December 27, 2019DOI:https://doi.org/10.1016/j.chest.2019.11.039
      COPD is a heterogeneous syndrome. Many COPD subtypes have been proposed, but there is not yet consensus on how many COPD subtypes there are and how they should be defined. The COPD Genetic Epidemiology Study (COPDGene), which has generated 10-year longitudinal chest imaging, spirometry, and molecular data, is a rich resource for relating COPD phenotypes to underlying genetic and molecular mechanisms. In this article, we place COPDGene clustering studies in context with other highly cited COPD clustering studies, and summarize the main COPD subtype findings from COPDGene. First, most manifestations of COPD occur along a continuum, which explains why continuous aspects of COPD or disease axes may be more accurate and reproducible than subtypes identified through clustering methods. Second, continuous COPD-related measures can be used to create subgroups through the use of predictive models to define cut-points, and we review COPDGene research on blood eosinophil count thresholds as a specific example. Third, COPD phenotypes identified or prioritized through machine learning methods have led to novel biological discoveries, including novel emphysema genetic risk variants and systemic inflammatory subtypes of COPD. Fourth, trajectory-based COPD subtyping captures differences in the longitudinal evolution of COPD, addressing a major limitation of clustering analyses that are confounded by disease severity. Ongoing longitudinal characterization of subjects in COPDGene will provide useful insights about the relationship between lung imaging parameters, molecular markers, and COPD progression that will enable the identification of subtypes based on underlying disease processes and distinct patterns of disease progression, with the potential to improve the clinical relevance and reproducibility of COPD subtypes.

      Key Words

      Abbreviations:

      GOLD ( Global Initiative for Chronic Obstructive Lung Disease), ICGC ( International COPD Genetics Consortium), TGF-β ( transforming growth factor-β)
      To read this article in full you will need to make a payment
      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rennard S.I.
        • Vestbo J.
        The many “small COPDs.”.
        Chest. 2008; 134: 623
        • Singh D.
        • Agustí A.G.N.
        • Anzueto A.
        • et al.
        Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019.
        Eur Respir J. 2019; 53: 1900164
        • Bhatt S.P.
        • Washko G.R.
        • Hoffman E.A.
        • et al.
        Imaging advances in chronic obstructive pulmonary disease. Insights from the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene) Study.
        Am J Respir Crit Care Med. 2019; 199: 286-301
        • Stringer W.W.
        • Porsasz J.
        • Bhatt S.P.
        • McCormack M.C.
        • Make B.J.
        • Casaburi R.
        Physiologic insights from the COPDGene study.
        Journal of the COPD Foundation. 2019; 6: 256-266
        • Maselli D.J.
        • Bhatt S.P.
        • Anzueto A.
        • et al.
        Clinical epidemiology of COPD: insights from 10 years of the COPDGene study.
        Chest. 2019; 156: 228-238
        • Ragland M.F.
        • Benway C.J.
        • Lutz S.M.
        • et al.
        Genetic advances in chronic obstructive pulmonary disease. Insights from COPDGene.
        Am J Respir Crit Care Med. 2019; 200: 677-690
        • Regan E.A.
        • Hersh C.P.
        • Castaldi P.J.
        • et al.
        Omics and the search for blood biomarkers in chronic obstructive pulmonary disease. Insights from COPDGene.
        Am J Respir Cell Mol Biol. 2019; 61: 143-149
        • Fletcher C.M.
        • Gilson J.G.
        • Hugh-Jones P.
        • Scadding J.G.
        Terminology, definitions, and classification of chronic pulmonary emphysema and related conditions: a report of the conclusions of a Ciba Guest Symposium.
        Thorax. 1959; 14: 286-299
        • Burrows B.
        • Niden A.H.
        • Fletcher C.M.
        • Jones N.L.
        Clinical types of chronic obstructive lung disease in London and in Chicago. A study of one hundred patients.
        Am Rev Respir Dis. 1964; 90: 14-27
        • Burrows B.
        • Fletcher C.M.
        • Heard B.E.
        • Jones N.L.
        • Wootliff J.S.
        The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and Chicago.
        Lancet. 1966; 1: 830-835
        • Donaldson G.C.
        • Seemungal T.A.R.
        • Bhowmik A.
        • Wedzicha J.A.
        Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.
        Thorax. 2002; 57: 847-852
        • Hurst J.R.
        • Vestbo J.
        • Anzueto A.
        • et al.
        Susceptibility to exacerbation in chronic obstructive pulmonary disease.
        N Engl J Med. 2010; 363: 1128-1138
        • Gibson P.G.
        • Simpson J.L.
        The overlap syndrome of asthma and COPD: what are its features and how important is it?.
        Thorax. 2009; 64: 728-735
        • Fishman A.
        • Martinez F.
        • Naunheim K.
        • et al.
        A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.
        N Engl J Med. 2003; 348: 2059-2073
        • Pistolesi M.
        • Camiciottoli G.
        • Paoletti M.
        • et al.
        Identification of a predominant COPD phenotype in clinical practice.
        Respir Med. 2008; 102: 367-376
        • Garcia-Aymerich J.
        • Gómez F.P.
        • Benet M.
        • et al.
        Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes.
        Thorax. 2011; 66: 430-437
        • Cho M.
        • Washko G.R.
        • Hoffmann T.J.
        • et al.
        Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation.
        Respir Res. 2010; 11: 30
        • Castaldi P.J.
        • Dy J.G.
        • Ross J.
        • et al.
        Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema.
        Thorax. 2014; 69: 415-422
        • Vanfleteren L.
        • Spruit M.
        • Groenen M.
        • et al.
        Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.
        Am J Respir Crit Care Med. 2013; 187: 728-735
        • Burgel P.R.
        • Paillasseur J.L.
        • Caillaud D.
        • et al.
        Clinical COPD phenotypes: a novel approach using principal component and cluster analyses.
        Eur Respir J. 2010; 36: 531-539
        • Pinto L.M.
        • Alghamdi M.
        • Benedetti A.
        • Zaihra T.
        • Landry T.
        • Bourbeau J.
        Derivation and validation of clinical phenotypes for COPD: a systematic review.
        Respir Res. 2015; 16: 50
        • Woodruff P.G.
        • Agustí A.G.N.
        • Roche N.
        • Singh D.
        • Martinez F.J.
        Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.
        Lancet. 2015; 385: 1789-1798
        • Woodruff P.G.
        • Modrek B.
        • Choy D.F.
        • et al.
        T-helper type 2-driven inflammation defines major subphenotypes of asthma.
        Am J Respir Crit Care Med. 2009; 180: 388-395
        • Agustí A.G.N.
        • Bel E.
        • Thomas M.
        • et al.
        Treatable traits: toward precision medicine of chronic airway diseases.
        Eur Respir J. 2016; 47: 410-419
        • McCarthy M.I.
        Painting a new picture of personalised medicine for diabetes.
        Diabetologia. 2017; 60: 793-799
        • Kinney G.L.
        • Santorico S.A.
        • Young K.A.
        • et al.
        Identification of chronic obstructive pulmonary disease axes that predict all-cause mortality: the COPDGene study.
        Am J Epidemiol. 2018; 187: 2109-2116
        • Regan E.A.
        • Hokanson J.E.
        • Murphy J.R.
        • et al.
        Genetic epidemiology of COPD (COPDGene) study design.
        COPD. 2010; 7: 32-43
        • Boueiz A.
        • Lutz S.M.
        • Cho M.
        • et al.
        Genome-wide association study of the genetic determinants of emphysema distribution.
        Am J Respir Crit Care Med. 2017; 195: 757-771
        • Boueiz A.
        • Pham B.
        • Chase R.
        • et al.
        Integrative genomics analysis identifies ACVR1B as a candidate causal gene of emphysema distribution.
        Am J Respir Cell Mol Biol. 2019; 60: 388-398
        • Boueiz A.
        • Chang Y.
        • Cho M.
        • et al.
        Lobar Emphysema distribution is associated with 5-year radiological disease progression.
        Chest. 2017; 153: 65-76
        • Chang Y.
        • Glass K.
        • Liu Y.Y.
        • et al.
        COPD subtypes identified by network-based clustering of blood gene expression.
        Genomics. 2016; 107: 51-58
        • Castaldi P.J.
        • Benet M.
        • Petersen H.
        • et al.
        Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts.
        Thorax. 2017; 72: 998-1006
        • Burgel P.R.
        • Paillasseur J.L.
        • Janssens W.
        • et al.
        A simple algorithm for the identification of clinical COPD phenotypes.
        Eur Respir J. 2017; 50: 1701034
        • Chen J.
        • Cho M.
        • Silverman E.K.
        • et al.
        Turning subtypes into disease axes to improve prediction of COPD progression.
        Thorax. 2019; 74: 906-909
        • Yun J.H.
        • Lamb A.
        • Chase R.
        • et al.
        Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.
        J Allergy Clin Immunol. 2018; 141: 2037-2047.e10
        • Vedel-Krogh S.
        • Nielsen S.F.
        • Lange P.
        • Vestbo J.
        • Nordestgaard B.G.
        Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The Copenhagen General Population Study.
        Am J Respir Crit Care Med. 2016; 193: 965-974
        • Zeiger R.S.
        • Tran T.N.
        • Butler R.K.
        • et al.
        Relationship of blood eosinophil count to exacerbations in chronic obstructive pulmonary disease.
        J Allergy Clin Immunol Pract. 2018; 6: 944-954.e5
        • Mendoza C.S.
        • Washko G.R.
        • Crapo J.D.
        • et al.
        Emphysema quantification in a multi-scanner HRCT cohort using local intensity distributions.
        Proc IEEE Int Symp Biomed Imaging. 2012; : 474-477
        • Castaldi P.J.
        • San José Estépar R.
        • Mendoza C.S.
        • et al.
        Distinct quantitative CT emphysema patterns are associated with physiology and function in smokers.
        Am J Respir Crit Care Med. 2013; 188: 1083-1090
        • Castaldi P.J.
        • Cho M.
        • San José Estépar R.
        • et al.
        Genome-wide association identifies regulatory loci associated with distinct local histogram emphysema patterns.
        Am J Respir Crit Care Med. 2014; 190: 399-409
        • Parker M.M.
        • Hao Y.
        • Guo F.
        • et al.
        Identification of an emphysema-associated genetic variant near TGFB2 with regulatory effects in lung fibroblasts.
        Elife. 2019; 8
        • Ross J.C.
        • Castaldi P.J.
        • Cho M.
        • et al.
        A Bayesian nonparametric model for disease subtyping: application to emphysema phenotypes.
        IEEE Trans Med Imaging. 2017; 36: 343-354
        • Ross J.C.
        • Castaldi P.J.
        • Cho M.
        • et al.
        Longitudinal modeling of lung function trajectories in smokers with and without chronic obstructive pulmonary disease.
        Am J Respir Crit Care Med. 2018; 198: 1033-1042
        • Lange P.
        • Celli B.
        • Agustí A.G.N.
        • et al.
        Lung-function trajectories leading to chronic obstructive pulmonary disease.
        N Engl J Med. 2015; 373: 111-122
        • Bui D.S.
        • Lodge C.J.
        • Burgess J.A.
        • et al.
        Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life.
        Lancet Respir Med. 2018; 6: 535-544
        • Agustí A.G.N.
        • Faner R.
        Lung function trajectories in health and disease.
        Lancet Respir Med. 2019; 7: 358-364
        • Sakornsakolpat P.
        • Prokopenko D.
        • Lamontagne M.
        • et al.
        Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations.
        Nature Genetics. 2019; 51: 494-505